Chris Riley's most recent trade in PLBY Group Inc was a trade of 9,590 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 23 May 2025 | 9,590 | 1,269,638 | - | 1.4 | 13,715 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 350,000 | 1,279,228 | - | 0 | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 274,187 | 929,228 | - | 0 | Common Stock | |
| Danaher | Christopher Paul Riley | Executive Vice President | Sale of securities on an exchange or to another person at price $ 198.05 per share. | 30 Apr 2025 | 8,004 | 15,179 (0%) | 0% | 198.1 | 1,585,216 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 7,801 | 0 | - | - | Employee stock option (right to buy) | |
| Danaher | Christopher Paul Riley | Executive Vice President | Sale of securities on an exchange or to another person at price $ 197.95 per share. | 30 Apr 2025 | 7,801 | 23,183 (0%) | 0% | 198.0 | 1,544,208 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.47 per share. | 30 Apr 2025 | 7,801 | 30,984 (0%) | 0% | 76.5 | 596,542 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 34,381 | 34,381 | - | - | Employee stock option (right to buy) | |
| Danaher | Christopher Paul Riley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 24,067 | 24,067 | - | - | Employee stock option (right to buy) | |
| Danaher | Christopher Paul Riley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 12,034 | 23,183 (0%) | 0% | 0 | Common Stock | |
| Danaher | Christopher Paul Riley | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.14 per share. | 24 Feb 2025 | 348 | 11,149 (0%) | 0% | 211.1 | 73,477 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.26 per share. | 01 Feb 2025 | 3,074 | 11,497 (0%) | 0% | 214.3 | 658,635 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 341 | 4,465 | - | - | Danaher Deferred Compensation Programs - Danaher Stock Fund | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Aug 2024 | 46,348 | 696,594 | - | 0.6 | 29,125 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Aug 2024 | 41,553 | 655,041 | - | 0.6 | 26,207 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 274,187 | 742,942 | - | 0 | Common Stock | |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 13,743 | - | - | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 24 May 2024 | 9,159 | 468,755 | - | 0.9 | 7,927 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 24 May 2024 | 7,603 | 477,914 | - | 0.9 | 6,732 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.46 per share. | 15 May 2024 | 320 | 14,581 (0%) | 0% | 263.5 | 84,307 | Common Stock |
| Danaher | Christopher Paul Riley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 11,632 | 11,632 | - | - | Employee stock option (right to buy) | |
| Danaher | Riley Christopher Paul | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.84 per share. | 26 Feb 2024 | 539 | 14,901 (0%) | 0% | 253.8 | 136,820 | Common Stock |
| Danaher | Christopher Riley Paul | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,367 | 15,440 (0%) | 0% | 0 | Common Stock | |
| Danaher | Christopher Riley Paul | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 375 | 4,115 | - | - | Danaher Deferred Compensation Programs - Danaher Stock Fund | |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Jun 2023 | 432,627 | 60,199,729 | - | 0 | Common Stock | |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 3,282 | - | - | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 23 Mar 2023 | 7,458 | 214,045 | - | 2.1 | 15,377 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 12 Dec 2022 | 9,555 | 221,503 | - | 3.8 | 36,574 | Common Stock |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2022 | 63,579 | 231,058 | - | 0 | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 22 Mar 2022 | 23,102 | 167,747 | - | 14.7 | 339,599 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 15.33 per share. | 22 Mar 2022 | 1,898 | 165,849 | - | 15.3 | 29,096 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Purchase of securities on an exchange or from another person at price $ 14.18 per share. | 22 Mar 2022 | 1,630 | 167,479 | - | 14.2 | 23,113 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 15.63 per share. | 18 Mar 2022 | 22,000 | 212,849 | - | 15.6 | 343,860 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 14.37 per share. | 18 Mar 2022 | 20,732 | 192,117 | - | 14.4 | 297,919 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 18 Mar 2022 | 1,268 | 190,849 | - | 15.3 | 19,400 | Common Stock |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 190,147 | 234,849 | - | 0 | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 39,469 | 44,702 | - | 0 | Common Stock | |
| PLBY Group Inc | Chris Riley | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 36,590 | 36,590 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Christopher Riley Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 42,950 | 42,950 | - | - | Stock Option (Right to Buy) |